212 related articles for article (PubMed ID: 10465075)
1. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa.
Rustomjee R; Abdool Karim Q; Abdool Karim SS; Laga M; Stein Z
AIDS; 1999 Aug; 13(12):1511-5. PubMed ID: 10465075
[TBL] [Abstract][Full Text] [Related]
2. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
[TBL] [Abstract][Full Text] [Related]
3. Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection.
Visness CM; Ulin P; Pfannenschmidt S; Zekeng L
Int J STD AIDS; 1998 Nov; 9(11):695-9. PubMed ID: 9863584
[TBL] [Abstract][Full Text] [Related]
4. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial.
Martin HL; Stevens CE; Richardson BA; Rugamba D; Nyange PM; Mandaliya K; Ndinya-Achola J; Kreiss JK
Sex Transm Dis; 1997 May; 24(5):279-83. PubMed ID: 9153737
[TBL] [Abstract][Full Text] [Related]
5. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
[TBL] [Abstract][Full Text] [Related]
6. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.
Van Damme L; Chandeying V; Ramjee G; Rees H; Sirivongrangson P; Laga M; Perriëns J
AIDS; 2000 Jan; 14(1):85-8. PubMed ID: 10714571
[TBL] [Abstract][Full Text] [Related]
7. Nonoxynol-9 in lubricated condoms. Results of a study in female prostitutes.
Ward H; De La Court A; Kitchen V
Sex Transm Dis; 1996; 23(5):413-4. PubMed ID: 8885074
[TBL] [Abstract][Full Text] [Related]
8. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
[TBL] [Abstract][Full Text] [Related]
9. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers.
Weir SS; Roddy RE; Zekeng L; Feldblum PJ
Genitourin Med; 1995 Apr; 71(2):78-81. PubMed ID: 7744418
[TBL] [Abstract][Full Text] [Related]
10. N-9 contraceptive film and the risk of STDs.
Netw Res Triangle Park N C; 1997; 17(3):5-7. PubMed ID: 12292395
[TBL] [Abstract][Full Text] [Related]
11. FHI study examines N-9 film effect on STDs. Contraceptive update.
Netw Res Triangle Park N C; 1997; 17(3):4-5. PubMed ID: 12292394
[TBL] [Abstract][Full Text] [Related]
12. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
13. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.
Van Damme L; Niruthisard S; Atisook R; Boer K; Dally L; Laga M; Lange JM; Karam M; Perriens JH
AIDS; 1998 Mar; 12(4):433-7. PubMed ID: 9520174
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial.
Richardson BA; Lavreys L; Martin HL; Stevens CE; Ngugi E; Mandaliya K; Bwayo J; Ndinya-Achola J; Kreiss JK
Sex Transm Dis; 2001 Jul; 28(7):394-400. PubMed ID: 11460023
[TBL] [Abstract][Full Text] [Related]
15. "We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.
Mantell JE; Morar NS; Myer L; Ramjee G
Am J Public Health; 2006 Jun; 96(6):1073-7. PubMed ID: 16670239
[TBL] [Abstract][Full Text] [Related]
16. Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives.
Witter FR; Barditch-Crovo P; Rocco L; Trapnell CB
Int J Gynaecol Obstet; 1999 May; 65(2):165-70. PubMed ID: 10405061
[TBL] [Abstract][Full Text] [Related]
17. Barrier contraceptive use and HIV infection among high-risk women in Cameroon.
Zekeng L; Feldblum PJ; Oliver RM; Kaptue L
AIDS; 1993 May; 7(5):725-31. PubMed ID: 8391273
[TBL] [Abstract][Full Text] [Related]
18. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.
Kreiss J; Ngugi E; Holmes K; Ndinya-Achola J; Waiyaki P; Roberts PL; Ruminjo I; Sajabi R; Kimata J; Fleming TR
JAMA; 1992 Jul 22-29; 268(4):477-82. PubMed ID: 1320133
[TBL] [Abstract][Full Text] [Related]
20. The use of spermicide containing nonoxynol-9 in the prevention of HIV infection.
Bird KD
AIDS; 1991 Jul; 5(7):791-6. PubMed ID: 1654056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
